Skip to content

Announcement: Generate:Biomedicines Named a Winner in Two Categories in Fast Company’s 2026 Best Workplaces for Innovators

Announcement: Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

Blog Post: Designing Beyond Tolerability Limits: Advancing GB-4362 Into Clinical Development

Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors

Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors

LinkedIn
X
YouTube

Presentations & Publications

GB-0895 COPD Phase 1 study ERS Barcelona 2026 Final

09.08.2026

Download as PDF

Now we can.

Generate:Biomedicines
101 South Street, Suite 900
Somerville, MA 02143
United States

© 2026 Generate:Biomedicines

LinkedIn
X
YouTube

Privacy Policy
Terms of Use
Cookie Settings